Literature DB >> 34602901

Update on the Role of the Gut Microbiota on Alcohol-Associated Liver Disease.

Bernd Schnabl1.   

Abstract

Entities:  

Year:  2021        PMID： 34602901      PMCID： PMC8475262     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.

Authors:  Jasmohan S Bajaj; Nita H Salzman; Chathur Acharya; Richard K Sterling; Melanie B White; Edith A Gavis; Andrew Fagan; Michael Hayward; Mary L Holtz; Scott Matherly; Hannah Lee; Majdi Osman; Mohammad S Siddiqui; Michael Fuchs; Puneet Puri; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2019-06-18       Impact factor: 17.425

2.  Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice.

Authors:  Tim Hendrikx; Yi Duan; Yanhan Wang; Jee-Hwan Oh; Laura M Alexander; Wendy Huang; Peter Stärkel; Samuel B Ho; Bei Gao; Oliver Fiehn; Patrick Emond; Harry Sokol; Jan-Peter van Pijkeren; Bernd Schnabl
Journal:  Gut       Date:  2018-11-17       Impact factor: 23.059

3.  Intestinal Virome in Patients With Alcoholic Hepatitis.

Authors:  Lu Jiang; Sonja Lang; Yi Duan; Xinlian Zhang; Bei Gao; Jessica Chopyk; Leila K Schwanemann; Meritxell Ventura-Cots; Ramon Bataller; Francisco Bosques-Padilla; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie L Shawcross; Samuel B Ho; Alexandre Louvet; Michael R Lucey; Philippe Mathurin; Guadalupe Garcia-Tsao; Tatiana Kisseleva; David A Brenner; Xin M Tu; Peter Stärkel; David Pride; Derrick E Fouts; Bernd Schnabl
Journal:  Hepatology       Date:  2020-10-10       Impact factor: 17.425

4.  Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis.

Authors:  Cyriac Abby Philips; Nikhil Phadke; Karthik Ganesan; Shatakshi Ranade; Philip Augustine
Journal:  Indian J Gastroenterol       Date:  2018-06-21

5.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.

Authors:  Yi Duan; Cristina Llorente; Sonja Lang; Katharina Brandl; Huikuan Chu; Lu Jiang; Richard C White; Thomas H Clarke; Kevin Nguyen; Manolito Torralba; Yan Shao; Jinyuan Liu; Adriana Hernandez-Morales; Lauren Lessor; Imran R Rahman; Yukiko Miyamoto; Melissa Ly; Bei Gao; Weizhong Sun; Roman Kiesel; Felix Hutmacher; Suhan Lee; Meritxell Ventura-Cots; Francisco Bosques-Padilla; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie L Shawcross; Samuel B Ho; Alexandre Louvet; Michael R Lucey; Philippe Mathurin; Guadalupe Garcia-Tsao; Ramon Bataller; Xin M Tu; Lars Eckmann; Wilfred A van der Donk; Ry Young; Trevor D Lawley; Peter Stärkel; David Pride; Derrick E Fouts; Bernd Schnabl
Journal:  Nature       Date:  2019-11-13       Impact factor: 49.962

6.  A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.

Authors:  Jasmohan S Bajaj; Edith A Gavis; Andrew Fagan; James B Wade; Leroy R Thacker; Michael Fuchs; Samarth Patel; Brian Davis; Jill Meador; Puneet Puri; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2021-03-16       Impact factor: 17.425
  6 in total
  1 in total

Review 1.  Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review.

Authors:  Roberta Forlano; Mathuri Sivakumar; Benjamin H Mullish; Pinelopi Manousou
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.